Ayala Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Ayala Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Ayala Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending December 31, 2023 was -$8.78M, a 9.72% increase year-over-year.
  • Ayala Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending December 31, 2023 was -$36.3M, a 3.3% increase year-over-year.
  • Ayala Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$36.3M, a 3.3% increase from 2022.
  • Ayala Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$37.5M, a 99.6% decline from 2021.
  • Ayala Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$18.8M, a 29% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$36.3M +$1.24M +3.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 -$37.5M -$18.7M -99.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 -$18.8M +$7.66M +29% Nov 1, 2020 Oct 31, 2021 10-K 2023-02-10
2020 -$26.4M -$8.48M -47.2% Nov 1, 2019 Oct 31, 2020 10-K 2022-02-14
2019 -$18M +$52.4M +74.5% Nov 1, 2018 Oct 31, 2019 10-K 2021-01-22
2018 -$70.4M +$28.1M +28.5% Nov 1, 2017 Oct 31, 2018 10-K 2019-12-20
2017 -$98.4M -$22M -28.7% Nov 1, 2016 Oct 31, 2017 10-K 2019-01-11
2016 -$76.5M -$27.8M -57.1% Nov 1, 2015 Oct 31, 2016 10-K 2017-12-21
2015 -$48.7M -$29.2M -149% Nov 1, 2014 Oct 31, 2015 10-K 2017-12-21
2014 -$19.5M -$4.84M -33% Nov 1, 2013 Oct 31, 2014 10-K 2017-01-09
2013 -$14.7M -$2.36M -19.1% Nov 1, 2012 Oct 31, 2013 10-K 2015-01-06
2012 -$12.3M +$684K +5.25% Nov 1, 2011 Oct 31, 2012 10-K 2014-01-29
2011 -$13M -$5.09M -64.3% Nov 1, 2010 Oct 31, 2011 10-K/A 2013-02-14
2010 -$7.93M Nov 1, 2009 Oct 31, 2010 10-K 2012-01-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.